A $5.5-million expansion at its Philadelphia, PA clinical supplies facility gives Catalent additional packaging and storage capacity.
Catalent Pharma Solutions has completed a $5.5-million-expansion program at its 200,000-sq.-ft. site in Philadelphia, PA, to provide additional clinical packaging and storage capacity. The facility is one of the largest sites in Catalent’s global clinical supply network, the company reported in an April 12, 2018 announcement.
The investment adds 40% more pallet space for refrigerated and ambient clinical storage, additional cold chain packaging areas, and a clinical label control area. The building also features a campus-wide environmental monitoring and building management system.
“The expansion not only allows us to meet the demand for additional capacity to serve large-scale clinical studies today, but also provides the space necessary for future growth,” said Albert Quintero, general manager, Clinical Supply Services.
Source: Catalent Pharma Solutions
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.